Developing new treatments can be a complex, lengthy and costly process. ReInvent explores the potential of using existing drugs or drug candidates for new treatment indications, with a particular focus on orphan drugs. Drug repurposing can potentially reduce development time and costs by building on existing knowledge and established safety profiles.
Learn MoreDrug repurposing involves exploring an existing drug or drug candidate for a new treatment indication for which it was not previously indicated.
Repurposing may shorten the pathway compared with developing an entirely new drug.
Existing knowledge about the drug may help reduce certain development uncertainties.
Existing safety information may provide a foundation for further evaluation.
A more efficient development pathway may have the potential to support faster access to treatment.
"To explore new possibilities for orphan drugs and contribute to more efficient pathways towards treatment development and patient access."
